Bristol-Myers Squibb Unusual Options Activity
Portfolio Pulse from Benzinga Insights
Unusual options activity has been observed in Bristol-Myers Squibb (NYSE:BMY), with 10 strange trades detected. Whales have been targeting a price range of $40 to $75 for the company over the last 3 months. Barclays maintains an Equal-Weight rating with a price target of $65, while Credit Suisse maintains a Neutral rating with a price target of $72.
May 25, 2023 | 8:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bristol-Myers Squibb (NYSE:BMY) has seen unusual options activity, with a price range of $40 to $75 targeted by whales. Analysts maintain mixed ratings, with Barclays at Equal-Weight and Credit Suisse at Neutral.
The unusual options activity in Bristol-Myers Squibb indicates increased interest from investors, but the mixed analyst ratings from Barclays and Credit Suisse suggest uncertainty in the stock's short-term direction. The targeted price range of $40 to $75 by whales also shows a wide range of potential outcomes. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100